All In MedTech

Device Trial Radar · NCT07757490

Sonablate HIFU International Registry for PC & BPH Patients

SONAFUSION Registry (Long-term Evaluation of Sonablate High-Intensity Focused Ultrasound for the Treatment of Prostate Cancer and Benign Prostatic Hyperplasia)

Last checked: Nov 21, 2026Latest source record: Aug 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

10,000

Planned (sponsor's estimate)

Start

Jan 1, 2015

Primary completion

Dec 2035

Study completion Dec 2035

Sponsor

Lead sponsor
SonablateNot on our public-company list
Sponsor type
Industry
Collaborators
Indiana University
First posted
Aug 11, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The SONA FUSION Registry is an observational study designed to evaluate the long-term effectiveness and safety of the Sonablate High-Intensity Focused Ultrasound (HIFU) system. This study focuses on adult men who have been treated for localized prostate cancer, benign prostatic hyperplasia (BPH) with urinary symptoms, or a combination of both conditions. The registry collects real-world medical data from multiple clinics globally to better understand how well the HIFU treatment controls disease and affects urinary and sexual function over a 10- to 20-year period. The study includes two groups of participants: a retrospective group of patients who previously received treatment, and a prospective group of newly treated patients receiving standard clinical care. No experimental interventions are assigned for the purpose of this study. To protect participant privacy, all medical data is completely de-identified and stripped of direct identifiers before being securely transferred to the central coordinating center at Indiana University. The ultimate goal of this research is to improve patient care protocols, advance men's health knowledge, and establish evidence-based guidelines for minimally invasive prostate treatments.

Conditions

  • Localized Prostate Cancer
  • BPH (Benign Prostatic Hyperplasia)
  • Prostate Cancer; Benign Prostatic Hyperplasia

Interventions

  • High Intensity Focused UltrasoundDevice

    Use of high intensity focused utrasound and sonatripsy for thermal and mechanical tissue ablation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Biochemical and Histological Recurrence-Free Survival RateTime frame: Baseline, and annually up to 10 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Indiana University Medical Center

    Indianapolis, Indiana · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.